Skip to main content
U.S. flag

An official website of the United States government

For providers Policy changes during COVID-19

Prescribing controlled substances via telehealth

During the COVID-19 public health emergency, authorized providers can prescribe controlled substances via telehealth, without the need for an in-person medical evaluation.

The Drug Enforcement Administration (DEA) has made 2 changes related to prescribing controlled substances while the COVID-19 public health emergency remains in effect.

  • A practitioner can prescribe a controlled substance to a patient using telemedicine, even if the patient isn’t at a hospital or clinic registered with the DEA
  • Qualifying practitioners can prescribe buprenorphine to new and existing patients with opioid use disorder based on a telephone evaluation

For more on the specific requirements for practitioners, see:

Last updated: January 28, 2021

Sign up for email updates

Get updates on telehealth
delivered to your inbox.